Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
orteronel (TAK 700)
i
Other names:
TAK 700, TAK-700
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Takeda
Drug class:
Androgen receptor antagonist, Lyase inhibitor
Related drugs:
‹
apalutamide (9)
nilutamide (4)
GT0918 (3)
BMS-641988 (2)
bicalutamide implant (2)
EPI-7386 (2)
HC-1119 (1)
IONIS-AR-2.5Rx (0)
sulforafan alfadex (0)
TAS3681 (0)
TQB3720 (0)
TRC253 (0)
cyproterone acetate (0)
TOK-001 (0)
EPI-506 (0)
INO-464 (0)
apalutamide (9)
nilutamide (4)
GT0918 (3)
BMS-641988 (2)
bicalutamide implant (2)
EPI-7386 (2)
HC-1119 (1)
IONIS-AR-2.5Rx (0)
sulforafan alfadex (0)
TAS3681 (0)
TQB3720 (0)
TRC253 (0)
cyproterone acetate (0)
TOK-001 (0)
EPI-506 (0)
INO-464 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
AR overexpression
Triple Negative Breast Cancer
AR overexpression
Triple Negative Breast Cancer
TAK 700
Sensitive: C3 – Early Trials
TAK 700
Sensitive
:
C3
TAK 700
Sensitive: C3 – Early Trials
TAK 700
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login